Form 4: CVS Health Executive James David Clark Reports Changes in Beneficial Ownership
SEC Form 4 Filing
SVP, Controller & Chief Accounting Officer of CVS Health, James David Clark, reports acquisition and disposal of CVS common stock and restricted stock units.
Summary
- James David Clark, SVP, Controller & Chief Accounting Officer of CVS Health, filed a Form 4 detailing changes in beneficial ownership.
- On April 1, 2025, Clark surrendered 2,266 shares of common stock to cover withholding taxes due upon the vesting and settlement of a restricted stock unit award at a price of $67.98.
- Also on April 1, 2025, Clark acquired 14,710 restricted stock units at a price of $67.98.
- Following these transactions, Clark beneficially owns 11,240 shares of common stock and 24,707 restricted stock units.
- The restricted stock units were awarded pursuant to CVS Health's 2017 Incentive Compensation Plan and vest in four equal installments starting April 1, 2026.
Sentiment
Score: 6
Explanation: Neutral sentiment. The filing simply reports transactions and doesn't inherently indicate positive or negative sentiment about the company's performance.
Positives
- The acquisition of restricted stock units suggests confidence in the company's future performance.
Future Outlook
The vesting schedule of the restricted stock units (starting 4/1/2026) incentivizes the executive to remain with the company and contribute to its long-term success.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.
Comparison to Industry Standards
- Executive compensation packages often include restricted stock units to align management's interests with those of shareholders.
- The vesting schedule of these units is typical, with vesting occurring over several years to encourage long-term commitment.
- Comparing Clark's holdings and transactions to those of executives at similar companies like Walgreens Boots Alliance (WBA) or UnitedHealth Group (UNH) could provide further context.
Stakeholder Impact
- Shareholders can use this information to understand executive compensation and alignment of interests.
- Employees may be interested in the company's equity compensation practices.
Key Dates
| Date | Description |
|---|---|
| 04/01/2025 | Date of common stock surrender and restricted stock unit acquisition. |
| 04/01/2026 | Commencement date for vesting of restricted stock units in four equal installments. |
| 04/03/2025 | Date of signature for the Form 4 filing. |
Keywords
Form 4, Beneficial Ownership, CVS Health, James David Clark, Restricted Stock Units, Common Stock, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.